Management of Acute Chlorantraniliprole Poisoning
Chlorantraniliprole poisoning should be managed with aggressive supportive care focused on cardiac monitoring and temporary pacing for conduction abnormalities, as there is no specific antidote for this insecticide.
Clinical Presentation and Mechanism
Chlorantraniliprole is an anthranilic diamide insecticide that activates ryanodine receptors, which can cause cardiac conduction defects in humans. The single documented human case 1 demonstrated development of symptomatic Mobitz Type I atrioventricular block requiring temporary pacemaker insertion, with spontaneous resolution after 48 hours.
Immediate Management Algorithm
1. Airway, Breathing, and Circulation
- Establish standard airway management and support breathing as needed 2
- Continuous cardiac monitoring is essential given the documented risk of conduction abnormalities 1
- Obtain 12-lead ECG immediately to assess for:
- AV blocks (particularly Mobitz Type I or higher-degree blocks)
- QRS prolongation
- QT interval changes
- Bradycardia
2. Decontamination (if presenting within 1-2 hours of ingestion)
- Do NOT induce vomiting
- Consider activated charcoal 1 g/kg (maximum 50 g) orally if:
- Patient presents within 1 hour of ingestion
- Airway is protected or can be protected
- No contraindications (altered mental status without protected airway, caustic ingestion)
3. Cardiac Management
For Bradycardia:
- Atropine 0.5-1.0 mg IV every 3-5 minutes up to 3 mg 2
- If refractory to atropine, prepare for temporary cardiac pacing 1
For Conduction Blocks:
- Mobitz Type I or higher-degree AV block: Immediate cardiology consultation and preparation for temporary transvenous pacing 1
- The documented case required pacemaker insertion and showed resolution within 48 hours 1
4. Supportive Care
- IV access with crystalloid fluids
- Treat hypotension with vasopressors if fluid-refractory (norepinephrine or epinephrine preferred) 2
- Serial cardiac monitoring for minimum 48-72 hours given the documented timeline to resolution 1
5. Laboratory Monitoring
- Serial electrolytes (particularly potassium, calcium, magnesium)
- Renal function
- Cardiac biomarkers if hemodynamically unstable
- Blood glucose
Critical Pitfalls to Avoid
Premature discharge: The documented case developed conduction abnormalities during observation 1. All patients require minimum 24-48 hours of continuous cardiac monitoring even if initially asymptomatic.
No specific antidote exists: Unlike organophosphate poisoning (which has atropine and pralidoxime) 2 or beta-blocker poisoning (which has glucagon and high-dose insulin) 2, chlorantraniliprole has no reversal agent. Management is purely supportive.
Ryanodine receptor mechanism: The unique mechanism of action (ryanodine receptor activation) 1 means standard toxicology antidotes are ineffective. Do not waste time attempting unproven therapies.
Consultation and Resources
Contact poison control immediately:
- United States: 1-800-222-1222 2
- Canada: Provincial poison center (https://infopoison.ca) 2
Request consultation with medical toxicologist for:
- Severe poisoning with hemodynamic instability
- Refractory conduction abnormalities
- Guidance on duration of monitoring
Expected Clinical Course
Based on the single documented human case 1:
- Conduction abnormalities may develop during observation period (not immediately)
- Temporary pacing may be required for 24-48 hours
- Spontaneous resolution typically occurs within 48 hours
- Full recovery is expected with appropriate supportive care
Disposition
- All patients: Admit to monitored bed (telemetry minimum) for 48 hours
- Symptomatic patients or those with conduction abnormalities: ICU admission with cardiology consultation
- Discharge criteria: 48 hours of normal cardiac rhythm, stable vital signs, and normal ECG
Human toxicity data for chlorantraniliprole remains extremely limited 1, making aggressive monitoring and supportive care the cornerstone of management until more evidence emerges.